Login to Your Account

Addex Strengthens Balance Sheet with $10M Placement

By Nuala Moran
Staff Writer

Wednesday, October 17, 2012
LONDON – Addex Therapeutics SA raised $10.3 million in a private placement, bolstering the balance sheet as it begins serious negotiations on partnering lead asset dipraglurant and awaits data from a Phase IIa trial of ADX71149 in treating schizophrenia.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription